Australian Pharmaceuticals & Biotech Most Popular Stocks

CSL

Market Cap: AU$82.0b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Telix Pharmaceuticals

Market Cap: AU$5.7b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Mesoblast

Market Cap: AU$2.8b

Engages in the development of regenerative medicine products in Australia.

Neuren Pharmaceuticals

Market Cap: AU$2.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

PYC Therapeutics

Market Cap: AU$2.3b

A clinical stage drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Clarity Pharmaceuticals

Market Cap: AU$880.5m

A clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceutical products for oncology in Australia and the United States.

Racura Oncology

Market Cap: AU$411.7m

Operates as a clinical-stage biopharmaceutical company in Australia.

Clinuvel Pharmaceuticals

Market Cap: AU$403.9m

A biopharmaceutical company, focuses on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders in Australia, Ireland, the United States, and internationally.

Starpharma Holdings

Market Cap: AU$374.3m

A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.

Tetratherix

Market Cap: AU$367.0m

Engages in biomaterial and regenerative medicine business in Australia and internationally.

Vitrafy Life Sciences

Market Cap: AU$288.8m

Engages in the research, development, and commercialization of cryopreservation solutions in Australia.

BLS Pharmaceuticals

Market Cap: AU$274.1m

Manufactures, imports, exports, and supplies controlled drugs and prescription medicines in Australia, the United Kingdom, Europe, and Japan.

Mayne Pharma Group

Market Cap: AU$258.4m

A specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.

Actinogen Medical

Market Cap: AU$219.4m

A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

Orthocell

Market Cap: AU$197.4m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally.

Aroa Biosurgery

Market Cap: AU$185.1m

Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.

Nyrada

Market Cap: AU$169.3m

A clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia.

Paradigm Biopharmaceuticals

Market Cap: AU$161.8m

Engages in the research and development of therapeutic products for human use in Australia.

Vita Life Sciences

Market Cap: AU$155.6m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

Dimerix

Market Cap: AU$150.1m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Island Pharmaceuticals

Market Cap: AU$133.2m

A drug repurposing company, focuses on the development of antiviral therapeutics for infectious diseases in Australia and the United States.

Recce Pharmaceuticals

Market Cap: AU$113.1m

Recce Pharmaceuticals Ltd, discovers, develops, and commercializes synthetic anti–infectives in Australia, the United Kingdom, and the United States.

Alterity Therapeutics

Market Cap: AU$104.9m

Engages in research and development of Parkinsonian and neurodegenerative disorders, including Multiple System Atrophy (MSA) and Parkinson’s disease.

Avecho Biotechnology

Market Cap: AU$88.9m

A biotechnology company, develops and commercializes human and animal health products using its proprietary drug delivery system, tocopherol phosphate mixture (TPM) in Australia, Switzerland, France, and India.

LTR Pharma

Market Cap: AU$84.5m

A clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.

Arovella Therapeutics

Market Cap: AU$73.7m

A biotechnology company, engages in the development of therapies for the treatment of cancer in Australia and internationally.

Prescient Therapeutics

Market Cap: AU$68.3m

A clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia.

Entropy Neurodynamics

Market Cap: AU$66.9m

A clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States.

Amplia Therapeutics

Market Cap: AU$66.7m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.

Immutep

Market Cap: AU$64.8m

A clinical-stage biotechnology company, develops lymphocyte activation gene-3 (LAG-3) related immunotherapies for cancer and autoimmune diseases in Australia.

Neurizon Therapeutics

Market Cap: AU$60.5m

A clinical stage biotechnology company, engages in the development of treatments for neurodegenerative diseases in Australia.

Little Green Pharma

Market Cap: AU$60.4m

Produces and sells cannabis-based medicinal products across Australia and Europe.

Medical Developments International

Market Cap: AU$58.6m

Provides emergency medical solutions in Australia, Europe, the United States, and internationally.

Cryosite

Market Cap: AU$57.6m

Provides outsourced clinical trials logistic services in Australia.

Botanix Pharmaceuticals

Market Cap: AU$52.0m

A pharmaceutical company, engages in the research and commercialization of solutions for skin diseases and infections in Australia and the United States.

Syntara

Market Cap: AU$47.1m

A clinical-stage drug development company, that targets extracellular matrix dysfunction through amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis in Australia.